Oncolytic Virus Immunotherapy Market Size, Share, Demand, and Forecast 2032
Oncolytic Virus Immunotherapy Market - By Application (Melanoma, Myeloma, Bladder Cancer, Ovarian Cancer, Prostrate Cancer, Lung Cancer, and Breast Cancer), By Product Type (HSV-based Oncolytic Viruses, Vaccinia Virus-based Oncolytic Viruses, Adenovirus-based Oncolytic Viruses, Newcastle Disease Virus-based Oncolytic Viruses, and Vesicular Stomatitis Virus-based Oncolytic Viruses), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024 - 2032-
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 2.70 Billion | USD 4.75 Billion | 6.5% | 2023 |
Table Of Content
- Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Type
- 1.3.2. Market Research Methodology
- Chapter 2. Executive Summary
- 2.1. Onculytic Virus Immunotherapy Market, 2018–2028(USD Million)
- 2.2. Onculytic Virus Immunotherapy Market: Snapshot
- Chapter 3. Global Onculytic Virus Immunotherapy Market– Industry Analysis
- 3.1. Onculytic Virus Immunotherapy Market: Market Dynamics
- 3.2. Market Drivers
- 3.2.1. Insights into mechanisms of virus replication, entry, induction, and immune response suppression has led to use of virus for treating human diseases along with selecting onculytic viral vectors for treating specific type of cancers. This will boost growth of onculytic virus immunotherapy market in coming years.
- 3.2.2. Immunotherapy is a major onculogy therapy targeting tumor biulogy and onculytic virus immunotherapy being most prominent among it. Additionally, the latter provides multimodal approach for effectively killing malignant cancer cells. This has resulted in humungous utility of onculytic virus immunotherapy in treating cancer, thereby driving industry trends.
- 3.3. Porter’s Five Forces Analysis
- 3.4. Market Attractiveness Analysis
- 3.4.1. Market attractiveness analysis By Application
- 3.4.2. Market attractiveness analysis By Product Type
- Chapter 4. Global Onculytic Virus Immunotherapy Market– Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global Onculytic Virus Immunotherapy Market: company market share, 2019
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New Product launches
- 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4. Research and development and Regional expansion
- 4.3. Price trend analysis
- 4.1. Company market share analysis
- Chapter 5. Global Onculytic Virus Immunotherapy Market– Application Analysis
- 5.1. Global Onculytic Virus Immunotherapy Market overview: By Application
- 5.1.1. Global Onculytic Virus Immunotherapy Market share, By Application, 2020 and 2028
- 5.2. Melanoma
- 5.2.1. Global Onculytic Virus Immunotherapy Market by Melanoma, 2018–2028(USD Million)
- 5.3. Myeloma
- 5.3.1. Global Onculytic Virus Immunotherapy Market by Myeloma, 2018–2028(USD Million)
- 5.4. Bladder Cancer
- 5.4.1. Global Onculytic Virus Immunotherapy Market by Bladder Cancer, 2018–2028(USD Million)
- 5.5. Prostrate Cancer
- 5.5.1. Global Onculytic Virus Immunotherapy Market by Prostrate Cancer, 2018–2028(USD Million)
- 5.6. Ovarian Cancer
- 5.6.1. Global Onculytic Virus Immunotherapy Market by Ovarian Cancer, 2018–2028(USD Million)
- 5.7. Culorectal Cancer
- 5.7.1. Global Onculytic Virus Immunotherapy Market by Culorectal Cancer, 2018–2028(USD Million)
- 5.8. Lung Cancer
- 5.8.1. Global Onculytic Virus Immunotherapy Market by Lung Cancer, 2018–2028(USD Million)
- 5.9. Breast Cancer
- 5.9.1. Global Onculytic Virus Immunotherapy Market by Breast Cancer, 2018–2028(USD Million)
- 5.1. Global Onculytic Virus Immunotherapy Market overview: By Application
- Chapter 6. Global Onculytic Virus Immunotherapy Market– Product Type Analysis
- 6.1. Global Onculytic Virus Immunotherapy Market overview: By Product Type
- 6.1.1. Global Onculytic Virus Immunotherapy Market share, By Product Type, 2020 and 2028
- 6.2. HSV-based Onculytic Viruses
- 6.2.1. Global Onculytic Virus Immunotherapy Market by HSV-based Onculytic Viruses, 2018–2028(USD Million)
- 6.3. Vaccinia Virus-based Onculytic Viruses
- 6.3.1. Global Onculytic Virus Immunotherapy Market by Vaccinia Virus-based Onculytic Viruses, 2018–2028(USD Million)
- 6.4. Vesicular Stomatitis Virus-based Onculytic Viruses
- 6.4.1. Global Onculytic Virus Immunotherapy Market by Vesicular Stomatitis Virus-based Onculytic Viruses, 2018–2028(USD Million)
- 6.5. Newcastle Disease Virus-based Onculytic Viruses
- 6.5.1. Global Onculytic Virus Immunotherapy Market by Newcastle Disease Virus-based Onculytic Viruses, 2018–2028(USD Million)
- 6.6. Adenovirus-based Onculytic Viruses
- 6.6.1. Global Onculytic Virus Immunotherapy Market by Adenovirus-based Onculytic Viruses, 2018–2028(USD Million)
- 6.1. Global Onculytic Virus Immunotherapy Market overview: By Product Type
- Chapter 7. Company Profiles
- 7.1. Amgen, Inc.
- 7.1.1. Overview
- 7.1.2. Financials
- 7.1.3. Product Portfolio
- 7.1.4. Business Strategy
- 7.1.5. Recent Developments
- 7.2. Genelux Corporation
- 7.2.1. Overview
- 7.2.2. Financials
- 7.2.3. Product Portfolio
- 7.2.4. Business Strategy
- 7.2.5. Recent Developments
- 7.3. Culd Genesys, Inc.
- 7.3.1. Overview
- 7.3.2. Financials
- 7.3.3. Product Portfolio
- 7.3.4. Business Strategy
- 7.3.5. Recent Development
- 7.4. Lokon Pharma AB
- 7.4.1. Overview
- 7.4.2. Financials
- 7.4.3. Product Portfolio
- 7.4.4. Business Strategy
- 7.4.5. Recent Development
- 7.5. Takara Bio
- 7.5.1. Overview
- 7.5.2. Financials
- 7.5.3. Product Portfolio
- 7.5.4. Business Strategy
- 7.5.5. Recent Development
- 7.6. Viralytics Ltd.
- 7.6.1. Overview
- 7.6.2. Financials
- 7.6.3. Product Portfolio
- 7.6.4. Business Strategy
- 7.6.5. Recent Development
- 7.7. Shanghai Sunway Biotech
- 7.7.1. Overview
- 7.7.2. Financials
- 7.7.3. Product Portfolio
- 7.7.4. Business Strategy
- 7.7.5. Recent Development
- 7.8. Onculytics Biotech, Inc.
- 7.8.1. Overview
- 7.8.2. Financials
- 7.8.3. Product Portfolio
- 7.8.4. Business Strategy
- 7.8.5. Recent Development
- 7.9. Vyriad
- 7.9.1. Overview
- 7.9.2. Financials
- 7.9.3. Product Portfolio
- 7.9.4. Business Strategy
- 7.9.5. Recent Development
- 7.10. VCN Biosciences
- 7.10.1. Overview
- 7.10.2. Financials
- 7.10.3. Product Portfolio
- 7.10.4. Business Strategy
- 7.10.5. Recent Development
- 7.11. Turnstone Biulogics
- 7.11.1. Overview
- 7.11.2. Financials
- 7.11.3. Product Portfolio
- 7.11.4. Business Strategy
- 7.11.5. Recent Development
- 7.12. Transgene sa
- 7.12.1. Overview
- 7.12.2. Financials
- 7.12.3. Product Portfolio
- 7.12.4. Business Strategy
- 7.12.5. Recent Development
- 7.13. DNAtrix Therapeutics
- 7.13.1. Overview
- 7.13.2. Financials
- 7.13.3. Product Portfolio
- 7.13.4. Business Strategy
- 7.13.5. Recent Development
- 7.1. Amgen, Inc.
Table Of Figures
List of Figures
1. Market research Type
2. Market research methodology
3. Global Oncolytic Virus Immunotherapy Market, 2018–2028(USD Million)
4. Porter’s Five Forces Analysis
5. Global Oncolytic Virus Immunotherapy Marketattractiveness, By Application
6. Global Oncolytic Virus Immunotherapy Marketattractiveness, By Product Type
7. Global Oncolytic Virus Immunotherapy Marketshare by Application ,2020 and 2028 (USD Million)
8. Global Oncolytic Virus Immunotherapy Marketby Melanoma, 2018–2028(USD Million)
9. Global Oncolytic Virus Immunotherapy Marketby Myeloma, 2018–2028(USD Million)
10. Global Oncolytic Virus Immunotherapy Marketby Bladder Cancer, 2018–2028(USD Million)
11. Global Oncolytic Virus Immunotherapy Marketby Prostrate Cancer, 2018–2028(USD Million)
12. Global Oncolytic Virus Immunotherapy Marketby Ovarian Cancer, 2018–2028(USD Million)
13. Global Oncolytic Virus Immunotherapy Marketby Breast Cancer, 2018–2028(USD Million)
14. Global Oncolytic Virus Immunotherapy Marketby Lung Cancer, 2018–2028(USD Million)
15. Global Oncolytic Virus Immunotherapy Marketshare by Product Type ,2020 and 2028 (USD Million)
16. Global Oncolytic Virus Immunotherapy Marketby HSV-based Oncolytic Viruses, 2018–2028(USD Million)
17. Global Oncolytic Virus Immunotherapy Marketby Vaccinia Virus-based Oncolytic Viruses, 2018–2028(USD Million)
18. Global Oncolytic Virus Immunotherapy Marketby Vesicular Stomatitis Virus-based Oncolytic Viruses, 2018–2028(USD Million)
19. Global Oncolytic Virus Immunotherapy Marketby Newcastle Disease Virus-based Oncolytic Viruses, 2018–2028(USD Million)
20. Global Oncolytic Virus Immunotherapy Marketby Adenovirus-based Oncolytic Viruses, 2018–2028(USD Million)
21. Global Oncolytic Virus Immunotherapy Marketshare, by Region, 2020 and 2028
22. North America Oncolytic Virus Immunotherapy Market, 2018–2028(USD Million)
23. Europe Oncolytic Virus Immunotherapy Market, 2018–2028(USD Million)
24. Asia Pacific Oncolytic Virus Immunotherapy Market, 2018–2028(USD Million)
25. Latin America Oncolytic Virus Immunotherapy Market, 2018–2028(USD Million)
26. The Middle East and Africa Oncolytic Virus Immunotherapy Market, 2018–2028(USD Million)
Table Of Tables
List of Tables
1. Global Oncolytic Virus Immunotherapy Market: snapshot
2. Drivers of the Oncolytic Virus Immunotherapy Market: impact analysis
3. North America Oncolytic Virus Immunotherapy Market revenue, By Application ,2018–2028(USD Million)
4. North America Oncolytic Virus Immunotherapy Market revenue, By Product Type ,2018–2028(USD Million)
5. The U.S. Oncolytic Virus Immunotherapy Market revenue, By Application ,2018–2028(USD Million)
6. The U.S. Oncolytic Virus Immunotherapy Market revenue, By Product Type ,2018–2028(USD Million)
7. Rest of North America Oncolytic Virus Immunotherapy Market revenue, By Application ,2018–2028(USD Million)
8. Rest of North America Oncolytic Virus Immunotherapy Market revenue, By Product Type ,2018–2028(USD Million)
9. Europe Oncolytic Virus Immunotherapy Market revenue, By Application ,2018–2028(USD Million)
10. Europe Oncolytic Virus Immunotherapy Market revenue, By Product Type ,2018–2028(USD Million)
11. UK Oncolytic Virus Immunotherapy Market revenue, By Application ,2018–2028(USD Million)
12. UK Oncolytic Virus Immunotherapy Market revenue, By Product Type ,2018–2028(USD Million)
13. France Oncolytic Virus Immunotherapy Market revenue, By Application ,2018–2028(USD Million)
14. France Oncolytic Virus Immunotherapy Market revenue, By Product Type ,2018–2028(USD Million)
15. Germany Oncolytic Virus Immunotherapy Market revenue, By Application ,2018–2028(USD Million)
16. Germany Oncolytic Virus Immunotherapy Market revenue, By Product Type ,2018–2028(USD Million)
17. Rest of Europe Oncolytic Virus Immunotherapy Market revenue, By Application ,2018–2028(USD Million)
18. Rest of Europe Oncolytic Virus Immunotherapy Market revenue, By Product Type ,2018–2028(USD Million)
19. Asia Pacific Oncolytic Virus Immunotherapy Market revenue, By Application ,2018–2028(USD Million)
20. Asia Pacific Oncolytic Virus Immunotherapy Market revenue, By Product Type ,2018–2028(USD Million)
21. China Oncolytic Virus Immunotherapy Market revenue, By Application ,2018–2028(USD Million)
22. China Oncolytic Virus Immunotherapy Market revenue, By Product Type ,2018–2028(USD Million)
23. Japan Oncolytic Virus Immunotherapy Market revenue, By Application ,2018–2028(USD Million)
24. Japan Oncolytic Virus Immunotherapy Market revenue, By Product Type ,2018–2028(USD Million)
25. India Oncolytic Virus Immunotherapy Market revenue, By Application ,2018–2028(USD Million)
26. India Oncolytic Virus Immunotherapy Market revenue, By Product Type ,2018–2028(USD Million)
27. Rest of Asia Pacific Oncolytic Virus Immunotherapy Market revenue, By Application ,2018–2028(USD Million)
28. Rest of Asia Pacific Oncolytic Virus Immunotherapy Market revenue, By Product Type ,2018–2028(USD Million)
29. Latin America Oncolytic Virus Immunotherapy Market revenue, By Application ,2018–2028(USD Million)
30. Latin America Oncolytic Virus Immunotherapy Market revenue, By Product Type ,2018–2028(USD Million)
31. Brazil Oncolytic Virus Immunotherapy Market revenue, By Application ,2018–2028(USD Million)
32. Brazil Oncolytic Virus Immunotherapy Market revenue, By Product Type ,2018–2028(USD Million)
33. Rest of Latin America Oncolytic Virus Immunotherapy Market revenue, By Application ,2018–2028(USD Million)
34. Rest of Latin America Oncolytic Virus Immunotherapy Market revenue, By Product Type ,2018–2028(USD Million)
35. The Middle East and Africa Oncolytic Virus Immunotherapy Market revenue, By Application ,2018–2028(USD Million)
36. The Middle East and Africa Oncolytic Virus Immunotherapy Market revenue, By Product Type ,2018–2028(USD Million)
37. Saudi Arabia Oncolytic Virus Immunotherapy Market revenue, By Application ,2018–2028(USD Million)
38. Saudi Arabia Oncolytic Virus Immunotherapy Market revenue, By Product Type ,2018–2028(USD Million)
39. South Africa Oncolytic Virus Immunotherapy Market revenue, By Application ,2018–2028(USD Million)
40. South Africa Oncolytic Virus Immunotherapy Market revenue, By Product Type ,2018–2028(USD Million)
41. Rest of the Middle East & Africa Oncolytic Virus Immunotherapy Market revenue, By Application ,2018–2028(USD Million)
42. Rest of the Middle East & Africa Oncolytic Virus Immunotherapy Market revenue, By Product Type ,2018–2028(USD Million)
Methodology
FrequentlyAsked Questions
Immunotherapy is a leading treatment in oncology with myriad therapies targeting tumor biology and oncolytic virus immunotherapy being one of the most promising ones. Additionally, the latter provides multimodal approach for effectively targeting & killing malignant tumors. This has resulted in massive use of oncolytic virus immunotherapy in cancer treatment, thereby driving market trends. Apparently, oncolytic virus immunotherapy is tailored for particular cell targets at specific locations and this is projected to have long lasting impact on drug molecule development for cancer treatment.
It has been found that oncolytic virus immunotherapy has the ability for inducing potent anti-tumoural effects that help in eliminating cancerous tissues and this has create a massive hype and demand for oncolytic virus immunotherapy in healthcare sector. Moreover, tumor specific oncolytic viruses have proved to be new anticancer agents and its efficacy is being tested intensely in phase I and phase III clinical trials. All these moves and aforementioned factors are projected to be key growth drivers for oncolytic virus immunotherapy market in near future.
Additionally, insights into mechanisms of virus replication, entry, induction, and immune response suppression has resulted into utilization of virus for treating human ailments along with choosing of oncolytic viral vectors for treatment of particular kinds of cancers. This will translate into charting of new growth path for oncolytic virus immunotherapy market in coming decade.
global Oncolytic Virus Immunotherapy Market was worth USD 2.70 Billion in 2023. The market is forecast to reach USD 4.75 Billion by 2032, growing at a compound annual growth rate (CAGR) of 6.5% during the forecast period 2024-2032.
North America will contribute lucratively towards the global market size over the estimated timeline. The regional market surge is due to rise in cases of cancer in North America. Additionally, large-scale presence of giant manufacturers & vendors in the U.S. and Canada will contribute lucratively towards regional market proceeds. Huge government funding of research activities related to novel therapies for cancer treatment & new drug development will proliferate size of oncolytic virus immunotherapy market in North America. Apparently, oncolytic virus immunotherapy industry is likely to experience huge growth prospects in sub-continent due to large proportion of sponsorships from cancer drug molecule manufacturers of the region.
The key market participants include Amgen, Inc., Genelux Corporation, Cold Genesys, Inc., Lokon Pharma AB, Takara Bio, Viralytics Ltd., Shanghai Sunway Biotech, Oncolytics Biotech, Inc., DNAtrix Therapeutics, Transgene sa, Turnstone Biologics, VCN Biosciences, and Vyriad.
RelatedNews
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed